Ghent University Academic Bibliography

Pembrolizumab monotherapy in sorafenib-treated and treatment-naïve advanced hepatocellular carcinoma : long-term follow-up of the open-label, phase II KEYNOTE-224 study

Richard S. Finn, Masatoshi Kudo, Ivan Borbath, Julien Edeline, Stephane Cattan, Hans Van Vlierberghe (UGent) , Chris Verslype, Daniel Palmer, Per Stal, Sadahisa Ogasawara, et al.

(2026) CLINICAL CANCER RESEARCH. 32(10). p.2007-2013

Add to list

Journal Article
A1
open access

Circadian genotypes in PER3 and time of prostate cancer radiotherapy interact to affect risk of late side-effects

Adam J. Webb, Emily Harper, Tim Rattay, Miguel E. Aguado-Barrera, Barbara Avuzzi, Renée Bultijnck (UGent) , Ananya Choudhury, Dirk K. De Ruysscher, Olivia Fuentes-Ríos, Sara Gutiérrez-Enríquez, et al.

(2026) CLINICAL CANCER RESEARCH. 32(19). p.4384-4395

Add to list

Journal Article
A1
open access

Safety and efficacy of tarlatamab in patients with neuroendocrine prostate cancer : results from the Phase 1b DeLLpro-300 study

Rahul Aggarwal, Sylvie Rottey (UGent) , Alice Bernard-Tessier, Begoña Mellado, Takeo Kosaka, Walter M Stadler, Lisa Horvath, Richard Greil, Bert O'Neil, Bilal A Siddiqui, et al.

(2025) CLINICAL CANCER RESEARCH. 31(18). p.3854-3863

Add to list

Journal Article
A1
open access

A phase I, first-in-human, dose-escalation, expansion trial of cytokine-encoding synthetic mRNA mixture alone or with cemiplimab in advanced solid tumors

Oliver Bechter, Carmen Loquai, Stephane Champiat, Jean-Francois Baurain, Jean-Jacques Grob, Jochen Utikal, Sylvie Rottey (UGent) , Alfonso Berrocal, Jessica C Hassel, Ana Arance, et al.

(2025) CLINICAL CANCER RESEARCH. 31(12). p.2358-2369

Add to list

Journal Article
A1
open access

Overall survival and exploratory biomarker analyses of abemaciclib plus trastuzumab with or without fulvestrant versus trastuzumab plus chemotherapy in HR+, HER2+ metastatic breast cancer patients

Sara M. Tolaney, Shom Goel, Jorge Nadal, Hannelore Denys (UGent) , Manuel R. Borrego, Lacey M. Litchfield, Jiangang Liu, Adams K. Appiah, Yanyun Chen and Fabrice André

(2024) CLINICAL CANCER RESEARCH. 30(1). p.39-49

Add to list

Journal Article
A1
open access

KLRG1 cell depletion as a novel therapeutic strategy in patients with mature T-cell lymphoma subtypes

Bimarzhan Assatova, Robert Willim, Christopher Trevisani, Garrett Haskett, Khyati Maulik Kariya, Kusha Chopra, Sung Rye Park, Michael Yevgeniy Tolstorukov, Sean M. McCabe, Jessica Duffy, et al.

(2024) CLINICAL CANCER RESEARCH. 30(11). p.2514-2530

Add to list

Journal Article
A1
open access

Biological sample collection to advance research and treatment : a fight osteosarcoma through European research and Euro Ewing Consortium statement

Darrell Green, Roelof van Ewijk, Elisa Tirtei, Dimosthenis Andreou, Fredrik Baecklund, Daniel Baumhoer, Stefan S. Bielack, Rajesh Botchu, Kjetil Boye, Bernadette Brennan, et al.

(2024) CLINICAL CANCER RESEARCH. 30(16). p.3395-3406

Add to list

Journal Article
A1
open access

Clinical characteristics and outcomes of central nervous system tumors harboring NTRK gene fusions

Audrey-Anne Lamoureux, Michael J. Fisher, Lauriane Lemelle, Elke Pfaff, Pouneh Amir-Yazdani, Christof Kramm, Bram De Wilde (UGent) , Bernarda Kazanowska, Caroline Hutter, Stefan M. Pfister, et al.

(2024) CLINICAL CANCER RESEARCH. 31(3). p.561-572

Add to list

A phase I study of acapatamab, a half-life extended, PSMA-targeting bispecific T-cell engager for metastatic castration-resistant prostate cancer

Tanya Dorff, Lisa G. Horvath, Karen Autio, Alice Bernard-Tessier, Matthew B. Rettig, Jean-Pascal Machiels, Mehmet A. Bilen, Martijn P. Lolkema, Nabil Adra, Sylvie Rottey (UGent) , et al.

(2024) CLINICAL CANCER RESEARCH. 30(8). p.1488-1500

Add to list

Zoledronic acid add-on therapy for standard-risk Ewing sarcoma patients in the Ewing 2008R1 trial

Raphael Koch, Lianne Haveman, Ruth Ladenstein, Benedicte Brichard, Heribert Jürgens, Sona Cyprova, Henk van den Berg, Wolf Hassenpflug, Anna Raciborska, Torben Ek, et al.

(2023) CLINICAL CANCER RESEARCH. 29(24). p.5057-5068

Academic Bibliography

Pembrolizumab monotherapy in sorafenib-treated and treatment-naïve advanced hepatocellular carcinoma : long-term follow-up of the open-label, phase II KEYNOTE-224 study

Circadian genotypes in PER3 and time of prostate cancer radiotherapy interact to affect risk of late side-effects

Safety and efficacy of tarlatamab in patients with neuroendocrine prostate cancer : results from the Phase 1b DeLLpro-300 study

A phase I, first-in-human, dose-escalation, expansion trial of cytokine-encoding synthetic mRNA mixture alone or with cemiplimab in advanced solid tumors

Overall survival and exploratory biomarker analyses of abemaciclib plus trastuzumab with or without fulvestrant versus trastuzumab plus chemotherapy in HR+, HER2+ metastatic breast cancer patients

KLRG1 cell depletion as a novel therapeutic strategy in patients with mature T-cell lymphoma subtypes

Biological sample collection to advance research and treatment : a fight osteosarcoma through European research and Euro Ewing Consortium statement

Clinical characteristics and outcomes of central nervous system tumors harboring NTRK gene fusions

A phase I study of acapatamab, a half-life extended, PSMA-targeting bispecific T-cell engager for metastatic castration-resistant prostate cancer

Zoledronic acid add-on therapy for standard-risk Ewing sarcoma patients in the Ewing 2008R1 trial

Contents

Support

Contact